Updated weekly ・ last 2026-10-03JAEN
Pharma Promotion / Incidents by company / Mallinckrodt

Mallinckrodt

11 incidents / jurisdictions: United States / sum of amounts reported: USD 881.9 m

DateJurisdictionOutcomeWhat happened (source)Damages / settlement / fine
2022-03-07United StatesSettlementMallinckrodt Agrees to Pay $260 Million to Settle Lawsuits Alleging Underpayments of Medicaid Drug Rebates and Payment of Illegal Kickbacks
U.S. Department of Justice + 1 more reports
$260 Million
2022-03-07United StatesSettlementMallinckrodt Agrees to Pay Nearly $234 Million to Resolve Allegations Related to Price Increases
U.S. Department of Justice
$234 Million / $233,707,865
2020-03-03United StatesFiled / under investigationUnited States Intervenes in False Claims Act Lawsuit against Drug Maker Mallinckrodt Alleging Company Knowingly Avoided Paying Medicaid Rebates Owed Due to Significant Price Increases
U.S. Department of Justice + 1 more reports
—
2020United StatesSettlementIn October 2020, Mallinckrodt filed for bankruptcy, which stayed the pending False Claims Act case. On March 2, 2022, the bankruptcy court confirmed Mallinckrodt’s plan of reorganization, which includ
Wikipedia: Mallinckrodt(Acthar controversy)
$234 million
2019-09-04United StatesSettlementDrug Maker Mallinckrodt Agrees to Pay $15.4 Million to Resolve False Claims Act Allegations for "Wining and Dining" Doctors
U.S. Department of Justice + 1 more reports
$15.4 Million / $15 Million
2019-06-05United StatesFiled / under investigationUnited States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks
U.S. Department of Justice
—
2018United StatesFiled / under investigationIn April 2018, a whistleblower lawsuit claimed Acthar, which had never passed a modern FDA process as Acthar had been available for 60 years and was thus passed under FDA "grandfathering" rules, had a
Wikipedia: Mallinckrodt(Acthar controversy)
—
2018United StatesFiled / under investigationA whistleblower filed a qui tam action in 2018 alleging that Mallinckrodt failed to pay the correct Medicaid rebates for Acthar in violation of the federal and state False Claims Acts . Medicaid Rules
Wikipedia: Mallinckrodt(Acthar controversy)
—
2017-07-11United StatesSettlementMallinckrodt Agrees to Pay Record $35 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs and for Recordkeeping Violations
U.S. Department of Justice + 2 more reports
$35 Million
2013-07-18United StatesSettlementPharmaceutical Company Agrees To Pay $3.5 Million To Settle False Claims Act Allegations
U.S. Department of Justice
$3.5 Million
2012United StatesSettlementIn December 2012, The New York Times , in an article on Mallinckrodt's main drug H.P. Acthar Gel, reported: "How the price of this drug rose so far, so fast is a story for these troubled times in Amer
Wikipedia: Mallinckrodt(Acthar controversy)
$100 million
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.